Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals.(Source : 201903 Annual Report Page No: 68)
Financial Results:
- Ipca Laboratories Ltd reported Revenues for Q1FY24 of ₹1,588.00 Crores up from ₹1,586.00 Crore year on year, a rise of 0.13%.
- Total Expenses for Q1FY24 of ₹1,380.00 Crores down from ₹1,386.00 Crores year on year, a fall of 0.43%.
- Consolidated Net Profit of ₹164.00 Crores up 13.1% from ₹145.00 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹6.42, up 13.83% from ₹5.64 in the same quarter of the previous year.